Insights On Trial Design

  1. Migrating A Live Personalized Medicine Trial To Next-Gen RTSM 3/26/2026

    Discover how a clinical-stage biotech automated its supply chain to protect patient enrollment and eliminate manual errors in a complex, multi-national genetic medicine trial.

  2. Together, We Are On A Mission: Enabling Treatments To Reach Patients 4/22/2026

    This AI-powered digital clinical trials platform enhances speed, scale, and patient access in clinical research, accelerating medicines for thousands of conditions without treatment or cure.

  3. Meeting Eye Exam Needs At The Point Of Need 3/11/2025

    Learn more about how mobile vision clinics supported the staff at trial sites as well as the patients through the COVID-19 pandemic and beyond.

  4. Harnessing Predictive Modeling To Overcome Trial Enrollment Challenges 2/28/2025

    By shifting from reactive problem-solving to proactive planning, predictive intelligence ensures clinical trials meet their enrollment goals more efficiently.

  5. Digital Physical Activity Measures In Phase 3 Immunology Trials 2/25/2025

    Dr. Jie Shen, Research Fellow and Director of Digital Science at AbbVie, shares lessons learned from incorporating digital measures of physical activity into Phase 3 immunology clinical trials.

  6. Decentralized And Community-Based Solutions Driving Women's Healthcare 9/24/2025

    Clinical trials should reflect the affected population by reducing participation barriers and bringing trials to patients to increase inclusion and improve real-world data.

  7. Scaling Oncology Trials Without Losing Momentum 5/1/2026

    As oncology programs expand, complexity often replaces momentum. Explore how scaling introduces hidden operational challenges and why anticipating continuity early helps teams stay aligned.

  8. Site Networks And Hybrid Solutions 7/22/2025

    Learn how community- and patient-centric site networks that have DCT capabilities are able to work with a broad-range of site types.

  9. How In-Home Trials Can Shift The Pediatric Rare Disease Research Landscape 1/6/2026

    DCT solutions are not just about bringing the trial to the patient’s home and reducing logistical burdens, but also strengthening the family-researcher connection.

  10. Pharma R&D Annual Review Supplement: New Active Substances 4/15/2026

    Last year was by some distance the best year ever in terms of new active substances. Explore the 105 new debuts that easily outstrips that of the previous record holder, 2021’s, 97.